Injector carrying case
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front right perspective view of an injector carrying case, showing our new design;
FIG. 2 is a rear elevational view thereof, the front elevational view being a mirror image thereof;
FIG. 3 is a left side elevational view thereof;
FIG. 4 is a top plan view thereof; and,
FIG. 5 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D338727
Type: Grant
Filed: Jun 18, 1991
Date of Patent: Aug 24, 1993
Assignee: Glaxo Group Limited (London)
Inventors: Paul K. Rand (Letchworth), Philip M. Regan (Cheshunt Herts)
Primary Examiner: Stella Reid
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 7/717,125
Type: Grant
Filed: Jun 18, 1991
Date of Patent: Aug 24, 1993
Assignee: Glaxo Group Limited (London)
Inventors: Paul K. Rand (Letchworth), Philip M. Regan (Cheshunt Herts)
Primary Examiner: Stella Reid
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 7/717,125
Classifications